Untreated HIV-1 infection and low CD4+ T cell counts and their effect on endemic human coronavirus (re)infection. by Ferdyansyah Sechan, Anne W M van den Hurk, T Sonia Boender, Maria Prins, Amy Matser, Margreet Bakker, Neeltje A Kootstra, Lia van der Hoek

Get full text

Untreated HIV-1 infection and low CD4+ T cell counts and their effect on endemic human coronavirus (re)infection by Ferdyansyah Sechan, Anne W. M. van den Hurk, T. Sonia Boender, Maria Prins, Amy Matser, Margreet Bakker, Neeltje A. Kootstra, Lia van der Hoek

Get full text

Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence by Alexander O. Pasternak, Pien M. van Paassen, Yara L. Verschoor, Jelmer Vroom, Karel A. van Dort, Irma Maurer, Marlous L. Grijsen, Ferdinand W. Wit, Godelieve J. de Bree, Neeltje A. Kootstra, Jan M. Prins, Ben Berkhout

Get full text

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction. by Nina Hertoghs, Bernadien M Nijmeijer, Nienke H van Teijlingen, Angharad E Fenton-May, Tanja M Kaptein, John L van Hamme, John C Kappes, Neeltje A Kootstra, Beatrice H Hahn, Persephone Borrow, Carla M S Ribeiro, Teunis B H Geijtenbeek

Get full text

Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls. by Thijs Booiman, Ferdinand W Wit, Arginell F Girigorie, Irma Maurer, Davide De Francesco, Caroline A Sabin, Agnes M Harskamp, Maria Prins, Claudio Franceschi, Steven G Deeks, Alan Winston, Peter Reiss, Neeltje A Kootstra, Co-morBidity in Relation to Aids (COBRA) Collaboration

Get full text

Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression. by Marloes Grobben, Margreet Bakker, Angela I Schriek, Liesbeth J J Levels, Jeffrey C Umotoy, Khadija Tejjani, Mariëlle J van Breemen, Ryan N Lin, Steven W de Taeye, Gabriel Ozorowski, Neeltje A Kootstra, Andrew B Ward, Stephen J Kent, P Mark Hogarth, Bruce D Wines, Rogier W Sanders, Amy W Chung, Marit J van Gils

Get full text

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines by Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Romy C. Dijkland, Marian van de Meent, Kayleigh van Dijk, Michel S. Bhoekhan, Nienke J.E. Haverkate, Johan van Meerloo, J.H. Frederik Falkenburg, Ruben A.L. de Groen, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Birgit I. Lissenberg-Witte, Arnon P. Kater, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sandra Vogels-Nooijen, Debbie van Baarle, Rory D. de Vries, Tom van Meerten, Pim G.N.J. Mutsaers, Abraham Goorhuis, Inger S. Nijhof, Mette D. Hazenberg, Mirjam H.M. Heemskerk, Caroline E. Rutten, COBRA KAI study team

Get full text